Role of population-based studies in assessing genetic cancer risk

Journal of the National Cancer Institute

Volumn 93, Issue 16, 2001, Pages 1188-1189

  Berry, D A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGE; BREAST CANCER; CANCER INCIDENCE; CANCER RESEARCH; CANCER RISK; CANCER SUSCEPTIBILITY; DIAGNOSTIC ACCURACY; EDITORIAL; EXON; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC RISK; HEREDITY; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK PATIENT; HUMAN; MUTATION RATE; PATIENT COUNSELING; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RANDOMIZATION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE STRAND CONFORMATION POLYMORPHISM; SWEDEN; UNITED KINGDOM;

EID: 0035880921     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.16.1188     Document Type: Editorial

References (9)

1. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer
2. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer
3. Population genetics of BRCA1 and BRCA2
4. Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): Comparison with DNA-SSCP
5. Current methods of mutation detection
6. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene
7. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history
8. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2
9. Testing for the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes: A decision analysis